![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jianyan Long, Ruiming Liang, Qiuyi Zheng, Gang Yuan, Ziyi Xin, Xinwen Chen, Fenghua Lai & Yihao Liu. (2021) Overview of Clinical Trials on Type 2 Diabetes Mellitus: A Comprehensive Analysis of the ClinicalTrials.gov Database. Diabetes, Metabolic Syndrome and Obesity 14, pages 367-377.
Read now
Read now
Xiao-Qian Li, Ge-Liang Yang, Kun-Ming Tao, Hui-Qing Zhang, Qing-Hui Zhou & Chang-Quan Ling. (2013) Comparison of registered and published primary outcomes in randomized controlled trials of gastroenterology and hepatology. Scandinavian Journal of Gastroenterology 48:12, pages 1474-1483.
Read now
Read now
Saroj Jayasinghe. (2011) Erosion of trust in humanitarian agencies: what strategies might help?. Global Health Action 4:1.
Read now
Read now
Tatyana Shamliyan. (2010) Reporting of results of interventional studies by the information service of the National Institutes of Health. Clinical Pharmacology: Advances and Applications 2, pages 169-176.
Read now
Read now
Articles from other publishers (15)
Rhonda G. Kost, Rita K. Devine, Mark Fernands, Riva Gottesman, Manoj Kandpal, Robert B. MacArthur, Barbara O’Sullivan, Michelle Romanick, Andrea Ronning, Sarah Schlesinger, Jonathan N. Tobin, Roger Vaughan, Maija Neville-Williams, James G. Krueger & Barry S. Coller. (2023) Building an infrastructure to support the development, conduct, and reporting of informative clinical studies: The Rockefeller University experience. Journal of Clinical and Translational Science 7:1.
Crossref
Crossref
J. J. Meerpohl, L. K. Schell, D. Bassler, S. Gallus, J. Kleijnen, M. Kulig, C. La Vecchia, A. Marusic, P. Ravaud, A. Reis, C. Schmucker, D. Strech, G. Urrutia, E. Wager & G. Antes. (2015) Evidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN (Overcome failure to Publish nEgative fiNdings) project based on an international consensus meeting. BMJ Open 5:5, pages e006666-e006666.
Crossref
Crossref
Ross J. BaldessariniRoss J. Baldessarini. 2013. Chemotherapy in Psychiatry. Chemotherapy in Psychiatry
1
29
.
Clara Pérez-Mañá, Carola Llonch & Magí Farré. (2012) Transparencia en la investigación clínica: registro de los ensayos clínicos y publicación de resultados. Medicina Clínica 139:13, pages 593-597.
Crossref
Crossref
Raphael Richard Ciuman. (2011) Sponsor-investigator-relationship: challenges, recent regulatory developments and future legislative trends. Health 03:12, pages 772-781.
Crossref
Crossref
Magdalena M. Reyes, Kaitlyn E. Panza, Andrés Martin & Michael H. Bloch. (2011) Time-Lag Bias in Trials of Pediatric Antidepressants: A Systematic Review and Meta-Analysis. Journal of the American Academy of Child & Adolescent Psychiatry 50:1, pages 63-72.
Crossref
Crossref
Charles Poole. (2010) A Vision of Accessible Epidemiology. Epidemiology 21:5, pages 616-618.
Crossref
Crossref
Tracy J. Beck. (2010) Can Clinical Trial Results Databases and Manuscripts Coexist?. Drug Information Journal 44:3, pages 271-277.
Crossref
Crossref
Kathy B. Thomas, Merete Joergensen, Gerard Lynch, Michael Rubison, Brandon D. Porter, Jacqueline Sayers & Claudia Tesch. (2010) Clinical Trial Disclosure: Global Overview and Implications of New Laws and Guidelines. Drug Information Journal 44:3, pages 213-225.
Crossref
Crossref
O. Bruyere, J. A. Kanis, M.-E. Ibar-Abadie, N. Alsayed, M. L. Brandi, N. Burlet, D. L. Cahall, A. Chines, J.-P. Devogelaer, W. Dere, N. Goel, N. Hughes, J.-M. Kaufman, S. Korte, B. H. Mitlak, D. Niese, R. Rizzoli, L. C. Rovati & J.-Y. Reginster. (2010) The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES). Osteoporosis International 21:5, pages 713-722.
Crossref
Crossref
Laurence J. Hirsch. (2009) Conflicts of Interest, Authorship, and Disclosures in Industry-Related Scientific Publications: The Tort Bar and Editorial Oversight of Medical Journals. Mayo Clinic Proceedings 84:9, pages 811-821.
Crossref
Crossref
H.J. Cloft, D.F. Kallmes & G. Lanzino. (2009) Buried Treasures: Unpublished Results of Industry-Sponsored Neurointerventional Trials. American Journal of Neuroradiology 30:8, pages 1457-1458.
Crossref
Crossref
E. Walker, M. C. Hankins & S. M. White. (2009) The effect of the European Clinical Trials Directive on published drug research in anaesthesia. Anaesthesia 64:9, pages 984-989.
Crossref
Crossref
Tony Tse, Rebecca J. Williams & Deborah A. Zarin. (2009) Reporting “Basic Results” in ClinicalTrials.gov. Chest 136:1, pages 295-303.
Crossref
Crossref
Frank W. Rockhold, Andrew J. Freeman & Craig A. Metz. (2012) Public Disclosure of Clinical Trial Results. Pharmaceutical Medicine 23:3, pages 131-137.
Crossref
Crossref